|
Zivo Bioscience Inc (ZIVO) |
|
Zivo Bioscience Inc
ZIVO's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Zivo Bioscience Inc 's sales fell
in the first quarter of 2025 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
growth of revenues by 12.76 %
Zivo Bioscience Inc net loss increased from $-2 millions, to $-4 millions in first quarter of 2025,
• More on ZIVO's Growth
|
|
Zivo Bioscience Inc realized a net loss in trailing twelve months.
Zivo Bioscience Inc realized cash reduction of $ -0.3 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 780.48.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.17.
• More on ZIVO's Valuation
|
|
|
|
|
Zivo Bioscience Inc realized net loss in trailing twelve months.
Zivo Bioscience Inc realized cash outflow of $ -0.3per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 780.48.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.17.
• More on ZIVO's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com